Latest Breaking News On - Zacks chemical - Page 1 : comparemela.com

Kronos Worldwide Q1 Earnings and Revenues Beat Estimates - Innospec (NASDAQ:IOSP), Kronos Worldwide (NYSE:KRO)

Kronos Worldwide Q1 Earnings and Revenues Beat Estimates - Innospec (NASDAQ:IOSP), Kronos Worldwide (NYSE:KRO)
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Kronos worldwideZacks consensus estimateZacks chemicalZacks rankZacks industry rank

Compass Minerals (CMP) Q1 Earnings and Revenues Miss Estimates

Compass (CMP) delivered earnings and revenue surprises of -79.17% and 7.21%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Compass mineralsZacks investment researchZacks consensus estimateZacks chemicalZacks rankStrong sellStrong buyZacks industry rankZacks investmentQuarterly earningsZacks rankArnings per shareStimate revisionsPs estimatesOnsensus estimateArnings surprise

Element Solutions (ESI) Q3 Earnings Beat Estimates

Element Solutions (ESI) delivered earnings and revenue surprises of 5.88% and 4.03%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Perimeter solutionsWhile element solutionsElement solutionsZacks investment researchZacks consensus estimateZacks chemicalZacks rankStrong buyZacks industry rankZacks investmentQuarterly earningsZacks rankStimate revisions

Kronos Worldwide (KRO) Reports Q2 Loss, Lags Revenue Estimates

Kronos Worldwide (KRO) delivered earnings and revenue surprises of -170% and 16.02%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks investment researchKronos worldwideZacks consensus estimateZacks chemicalZacks rankStrong sellStrong buyZacks industry rankZacks investment

Ingevity (NGVT) Meets Q2 Earnings Estimates

Ingevity (NGVT) delivered earnings and revenue surprises of 0% and 0.36%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Amyris incZacks investment researchZacks consensusZacks chemicalZacks consensus estimateZacks rankStrong buyZacks industry rankZacks investmentQuarterly earningsZacks rankStimate revisionsOnsensus estimatePs estimatesConsensus eps estimateArnings estimate